A study in people with overweight or obesity to test how BI 1820237, BI 456906, or a combination of both affects brain activity
1458-0006
Phase 1 other active
Quick answer
A study in people with overweight or obesity to test how BI 1820237, BI 456906, or a combination of both affects brain activity for Obesity is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Obesity
- Phase
- Phase 1
- Modality
- other
- Status
- active